Recalling Rosacea's Onset

Some information on progression that may be useful for reassuring patients

Should a patient with mild erythematotelangiectatic rosacea worry about disease progression to papules, pustules, phymas, and eye involvement? The answer is probably no, but a recent survey suggests a “progression march” may occur. Investigators in northern Germany recruited 135 subjects with rosacea to participate in a manufacturer-supported, noninterventional, cross-sectional examination and survey. Subjects had at least one of the four rosacea subtypes: erythematotelangiectatic rosacea (ETR), papulopustular rosacea (PPR), phymatous rosacea (PHY), or ocular rosacea (OR). Many had more than one type.

There were some surprises: PHY was significantly more frequently associated with PPR than with ETR alone. Edema was not observed in ETR but di…

Reviewing Author

Mark V. Dahl, MD

Disclosures

Consultant / Advisory board Ulthera, Inc.; AuBio LifeSciences, LLC; Paris Therapeutics

Equity Elorac, Inc.; Makucell, Inc.; Paris Therapeutics

Editorial boards UpToDate

Leadership positions in professional societiesNational Rosacea Society (Chairman, Medical Board)

Mark V. Dahl, MD

Disclosures

Consultant / Advisory board Ulthera, Inc.; AuBio LifeSciences, LLC; Paris Therapeutics

Equity Elorac, Inc.; Makucell, Inc.; Paris Therapeutics

Editorial boards UpToDate

Leadership positions in professional societiesNational Rosacea Society (Chairman, Medical Board)